News

Surrogacy goes more mainstream

By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

U.S. Federal

Eugenics and the Modern Synthesis, Part I

By Jessica Riskin, Los Ángeles Review of Books | 03.23.2026

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...

Civil Society

Surrogacy laws are all over the map

By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing...

Policies

Project Eugenics: The Rollback of Disability Rights

By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026

"MC0_8230" via Wikimedia Commons licensed under CC by 2.0 

This report documents a deliberate assault on disabled people in...

U.S. States

DNA Day Hype

By Nathaniel Comfort, Genotopia | 04.25.2014

Happy DNA Day everyone. On this date in 1953, Nature published four articles on the structure of DNA, including the...

Bioethics

Infertility, Endured Through a Prism of Race

By Tanzina Vega, The New York Times | 04.25.2014
WASHINGTON — Like many single women, Heather Lawson hoped she would meet the right man with enough time to get...
Public Opinion

Neanderthals Are People, Too

By Svante Paabo, The New York Times | 04.24.2014
LEIPZIG, Germany — I NEVER met my paternal grandfather. He died of the Spanish flu in 1919 at the age...
Bioethics

Guidelines for Finding Genetic Variants Underlying Human Disease

By Daniel MacArthur and Chris Gunter, Genomes Unzipped | 04.24.2014

New DNA sequencing technologies are rapidly transforming the diagnosis of rare genetic diseases, but they also carry a risk: by...

Biotech & Pharma

Bracing For A Battle, Vermont Passes GMO Labeling Bill

By Eliza Barclay and Jeremy Bernfeld, NPR | 04.24.2014
The Green Mountain State is poised to become the first to require food companies to label products containing genetically modified...
Biopolitics

Invoking ‘Choice’ When Discussing Surrogacy as a Feminist Concern is a Mistake

By Susan Berke Fogel, Francine Coeytaux, Marcy Darnovsky, Lisa Ikemoto, and Judy Norsigian, RH Reality Check | 04.23.2014
It is troubling to see the vexing question of commercial surrogacy treated as a litmus test for feminists at RH...
Bioethics

NIPS SPIN

By Robert Resta, The DNA Exchange | 04.21.2014
Untitled Document

Advertising is the art of making whole lies out of half truths. ~Edgar A. Shoaff

Every few...

Genomics

Is Illumina’s $1,000 Genome a Reality? Not for Clinical Laboratory Purposes, Asserts an In Vitro Diagnostics Expert

By Joseph Burns, Dark Daily | 04.21.2014
Untitled Document

It was January when headlines nationwide trumpeted Illumina’s introduction of the $1,000 genome. The story in ...

Biotech & Pharma